EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES. (2025). The Research of Medical Science Review, 3(5), 290-294. http://thermsr.com/index.php/Journal/article/view/1109